CorVel Corporation (CRVL) Earnings Call Transcripts

18 earnings calls from February 2020 to August 5, 2026

NasdaqGS US Health Care Health Care Providers and Services

CorVel Corporation's Latest Earnings Call - Q4 FY2026

In the March quarter of fiscal year 2026, CorVel Corporation reported revenues of $249 million, a 7% increase year-over-year, and earnings per share (EPS) of $0.61, up from $0.51. For the full fiscal year, revenues reached $959 million, also a 7% increase, while EPS rose 17% to $2.14. Management highlighted strong performance in Network Solutions and a significant increase in new bookings, which rose 56% year-over-year, indicating robust demand and potential future revenue growth.

Reported metrics

MetricValueContext
Quarterly Revenue $249 million (beat) vs $232 million in Q1 2025, +7% YoY
Quarterly EPS $0.61 (beat) vs $0.51 in Q1 2025, +20% YoY
Fiscal Year Revenue $959 million (beat) vs $896 million in FY 2025, +7% YoY
Fiscal Year EPS $2.14 (beat) vs $1.83 in FY 2025, +17% YoY
Operating Margin 15% (positive) vs 13.6% in FY 2025, +1.4% YoY
Net Income $110 million (beat) vs $95 million in FY 2025, +14% YoY

Guidance from management

Management did not provide specific numerical guidance for the upcoming quarter or fiscal year but indicated that ongoing revenue and profit growth is expected from new payer programs and technology investments.

What management said

Thank you. Good morning. Thank you for joining us to review CorVel's March quarter and fiscal year results. Brian Nichols, CorVel's Chief Financial Officer, is on the call with me today. Today, I will review business performance, the current environment and market trends and progress on product and service offerings. So let's start with Brian providing an overview of the March quarter and fiscal year results. Brian?
— Michael Combs, Q4 FY2026 earnings call

What analysts pressed on

Analysts expressed concerns regarding the sustainability of the recent surge in new bookings and the impact of rising administrative costs in the healthcare sector. There were questions about how CorVel plans to maintain operational efficiency amidst increasing claims complexity and market pressures.

Main topics on the call

Read the full CorVel Corporation transcript (Q4 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

About CorVel Corporation

CorVel Corporation (CRVL) is a publicly listed company in the Health Care Providers and Services industry, within the Health Care sector. It trades on NasdaqGS and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 18 calls on record spanning February 4, 2020 to August 5, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 18 CorVel Corporation earnings call transcripts on record, spanning February 4, 2020 to August 5, 2026. Based on this history, CorVel Corporation reports semi-annually. The most recent call on file is dated August 5, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
CRVL
Exchange
NasdaqGS
Country
US
Sector
Health Care
Industry
Health Care Providers and Services
Calls on record
18
First call
February 4, 2020
Most recent
August 5, 2026
Reporting cadence
semi-annually
Quarter Date
Q1 FY2027 Aug 5, 2026 Read transcript
Q4 FY2026 May 20, 2026 Read transcript
Q3 FY2026 Feb 3, 2026 Read transcript
Q2 FY2026 Nov 4, 2025 Read transcript
Q3 FY2025 Feb 4, 2025 Read transcript
Q3 FY2023 Jan 31, 2023 Read transcript
Q2 FY2023 Nov 1, 2022 Read transcript
Q1 FY2023 Aug 2, 2022 Read transcript
Earnings Calls May 26, 2022 Read transcript
Q3 FY2022 Feb 1, 2022 Read transcript
Q2 FY2022 Nov 2, 2021 Read transcript
Q1 FY2022 Aug 3, 2021 Read transcript
Earnings Calls May 27, 2021 Read transcript
Q3 FY2021 Feb 2, 2021 Read transcript
Q2 FY2021 Nov 3, 2020 Read transcript
Q1 FY2021 Aug 4, 2020 Read transcript
Earnings Calls May 27, 2020 Read transcript
Q3 FY2020 Feb 4, 2020 Read transcript